TY - JOUR
T1 - Cognitive-behavioral treatment for depression in smoking cessation
AU - Brown, Richard A.
AU - Kahler, Christopher W.
AU - Niaura, Raymond
AU - Abrams, David B.
AU - Sales, Suzanne D.
AU - Ramsey, Susan E.
AU - Goldstein, Michael G.
AU - Burgess, Ellen S.
AU - Miller, Ivan W.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Cigarette smokers with past major depressive disorder (MDD) received 8 group sessions of standard, cognitive-behavioral smoking cessation treatment (ST; n = 93) or standard, cognitive-behavioral smoking cessation treatment plus cognitive-behavioral treatment for depression (CBT-D; n = 86). Although abstinence rates were high in both conditions (ST, 24.7%; CBT-D, 32.5%, at 1 year) for these nonpharmacological treatments, no main effect of treatment was found. However, secondary analyses revealed significant interactions between treatment condition and both recurrent depression history and heavy smoking (≥25 cigarettes a day) at baseline. Smokers with recurrent MDD and heavy smokers who received CBT-D were significantly more likely to be abstinent than those receiving ST (odds ratios = 2.3 and 2.6, respectively). Results suggest that CBT-D provides specific benefits for some, but not all, smokers with a history of MDD.
AB - Cigarette smokers with past major depressive disorder (MDD) received 8 group sessions of standard, cognitive-behavioral smoking cessation treatment (ST; n = 93) or standard, cognitive-behavioral smoking cessation treatment plus cognitive-behavioral treatment for depression (CBT-D; n = 86). Although abstinence rates were high in both conditions (ST, 24.7%; CBT-D, 32.5%, at 1 year) for these nonpharmacological treatments, no main effect of treatment was found. However, secondary analyses revealed significant interactions between treatment condition and both recurrent depression history and heavy smoking (≥25 cigarettes a day) at baseline. Smokers with recurrent MDD and heavy smokers who received CBT-D were significantly more likely to be abstinent than those receiving ST (odds ratios = 2.3 and 2.6, respectively). Results suggest that CBT-D provides specific benefits for some, but not all, smokers with a history of MDD.
UR - http://www.scopus.com/inward/record.url?scp=0034913865&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034913865&partnerID=8YFLogxK
U2 - 10.1037/0022-006X.69.3.471
DO - 10.1037/0022-006X.69.3.471
M3 - Article
C2 - 11495176
AN - SCOPUS:0034913865
SN - 0022-006X
VL - 69
SP - 471
EP - 480
JO - Journal of consulting and clinical psychology
JF - Journal of consulting and clinical psychology
IS - 3
ER -